Chronic Migraine is officially regulated as a social disease in Italy

2020-07-15T09:47:12+00:0015/07/2020|Categories: News|

The Italian senate has approved the recognition of primary chronic headache as a social disease,  a huge step towards the acknowledgment of migraine as the serious illness it is.   On April 18, 2019 the Chamber passed the bill and 15 months later it was finally approved by the Italian Senate. This achievement reflects the struggle of migraine patients, and it comes as a fair recognition of their condition, setting a historic goal which could be the previous step to improvements in the diagnosis, the social conditions and the therapeutic approaches of patients suffering from primary chronic head pain.   [...]

Read the latest publications by EMHA on Migraine At Work

2020-07-01T09:47:21+00:0019/06/2020|Categories: News|

All the articles are based on the survey led by EMHA on Migraine at work. Read the survey on the following link to find out more about the study:   SEMERGEN publication European Survey on preventive treatments on migraine Medicina Balear Magazine EMHA at Work: SED Publication Survey        

Covid-19 & migraine and other headaches: Webinar by Vall d’Hebron

2020-05-08T09:14:28+00:0008/05/2020|Categories: Events, Industry, News|

Watch the first webinar for patients on Covid-19 and its impact on migraine and other headaches streamed by Vall d’Hebron Hospital with the support of EMHA. Learn about the impact of the virus on patients with migraine, the possible risks associated with the treatments and advice on reducing the negative  impact of the lock down during migraine and other headaches episodes.

Migraine at work

2020-04-28T14:13:01+00:0028/04/2020|Categories: News|

European survey. Analysis of results and conclusions. The objective of this study is to know the situation of migraine workers within the workplace and compare the situation in the different participating countries. Read de complete document in our Publications section

EMHA & Allergan meeting focus

2020-01-31T12:43:18+00:0024/01/2020|Categories: Meeting, News|

Elena Ruiz de la Torre, Executive Director of EMHA attended a business meeting on 23 January with the Allergan Company. The purpose of the meeting was to share ideas and priorities to explore areas of collaboration and identify opportunities. We also took the opportunity to share the history of migraine with Allergan Marlow employees. The attendees of the meeting focus were: EMHA:   Elena Ruiz de la Torre - Executive Director. Allergan:    Maria Fantis - Marketing, Neurosciences. Gwyn Grenrock - The Allergan Foundation. Mark Marmur - International Communications & Public Relations. Katherine Sommer - Medical Affairs, Migraine. Susan Stone [...]

We and our partners use cookies, to collect browsing data to give you the best online experience and to personalize the content, play multimedia content, interact with social networks and perform browsing analytics. If you continue browsing we understand you accept the use of such technology. For more information visit our cookies policy Find out more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.